PCC SE contributes MCAA subsidiaries into PCC Rokita to consolidate chlorine & derivatives
- Contribution agreement signed on October 15 after a letter of intent on June 16.
- Final valuation of the two MCAA subsidiaries: EUR 61.4 million.
- PCC SE receives 4,027,312 newly issued PCC Rokita shares, raising its stake to 76.4% and voting rights to 83.3%.
- MCAA production and marketing will be integrated into PCC Rokita; transaction requires general-meeting approval and share registration to complete.
Transaction structure
PCC SE contributed its subsidiaries MCAA SE and PCC MCAA Sp. z o.o. into PCC Rokita SA by way of a share swap. The final valuation of the two companies is EUR 61.4 million. Based on a six‑month volume‑weighted average PCC Rokita share price of PLN 66.11, PCC SE receives 4,027,312 newly issued PCC Rokita shares.
Ownership impact
As a result of the share issue, PCC SE's shareholding in PCC Rokita increases from 71.7% to 76.4%; its voting rights rise from 81.0% to 83.3%. The contribution agreement was signed on October 15, following a letter of intent dated June 16.
Operational integration and next steps
Operationally, the production and marketing of monochloroacetic acid (MCAA) will be integrated directly into PCC Rokita, which produces chlorine — the key raw material for MCAA — to centralise management and pursue process optimisations and synergies. The issuance of the new shares requires approval at a PCC Rokita general meeting and the transaction will be completed once the newly issued shares are registered in the Polish register.
Source: PCC SE